Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial

NCT05468892 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colon Cancer

Interventions

DRUG: Trifluridine Tipiracil
DRUG: Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]

Sponsor

University of Campania Luigi Vanvitelli